Soil microbiomes are among the most diverse microbial communities on Earth. They also play an immense role in cycling soil carbon, nitrogen, and other nutrients that underpin the terrestrial food web.

Researchers at the U.S. Department of Energy’s Pacific Northwest National Laboratory and Kansas State University found that soil drying significantly affected the structure and function of soil microbial communities.

A PNNL study that evaluated the use of friction stir technology on stainless steel has shown that the steel resists erosion more than three times that of its unprocessed counterpart.

PNNL’s Janet Jansson is part of an international team of scientists warning scientists of the urgency to pay more attention to the role of microorganisms in our climate.

PNNL has developed a technology to manufacture rods and tubes directly from high-performance aluminum alloy powder—in just one single step.

PNNL researchers today published a pair of papers, in Cell and in Nature, exploring the effects of the gut microbiome on our health, including autism, brain function, and inflammatory bowel disease.

Keerti S. Kappagantula, a scientist in PNNL’s Energy Processes and Materials Division, was featured in ASM International’s Women in Engineering Series.

A new technology that offers a novel way to manufacture extrusions with unprecedented improvements in material properties recently received a U.S. patent.

PNNL is advancing scientific frontiers and addressing challenges in energy, the environment and national security. So, in no particular order, here are PNNL's top 10 research accomplishments of 2018

Study investigates a common human exposure coupled with a high-fat diet.

New technique developed by PNNL successfully joins thicker aluminum alloys to steel

Researchers discover how certain bacteria may safeguard plant growth during a drought, making way for strategies to improve crop productivity

PNNL leads team to accelerate development of affordable carbon fiber composites

Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.